Delivery Order SPE2DB24D1205-SPE2DB24FCUJT

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,891,268 units of the pharmaceutical product Januvia 100 mg tablets. The contract has a firm fixed price of $19,300.14 and a completion date of September 23, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical commodities, including...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Januvia 100 mg tablets. The contract has a firm fixed price of $8,566.40 and an ultimate completion date of September 23, 2024. It is not a set-aside contract. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, for delivering a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Januvia 100 mg tablets. The contract has a firm-fixed price of $8,982.23 and an ultimate completion date of August 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2025. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Januvia 100 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $29,767.58 and a period of performance through June 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4,567,749,712 units of the drug Januvia 100 mg tablets. The contract has a firm fixed price of $5,924.58 and a completion date of April 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,558,460,814 units of the drug Januvia 100 mg tablets, valued at $5,090.86. The contract is a firm-fixed-price delivery order with a completion date of September 15, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,158.00 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product JANUVIA 100 MG TABLET 90S, with a period of performance through May 6, 2024. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. The IDC enables the DLA to efficiently procure a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of JANUVIA 100 mg tablets. The contract has a ceiling value of $37,920.36 and a period of performance ending on September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,940.36, is for the delivery of 4,563,927,477 units of the drug Januvia 100 mg tablets. The contract has a firm fixed price and an ultimate completion date of March 12, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 1,000 units of Januvia 100 mg tablets. The award has a ceiling value of $19,984.21 and a completion date of October 8, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000 respectively, for providing a wide range of medical...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCUJT
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,684 units of the drug Januvia 100 mg tablets. The contract has a firm fixed price of $10,138.39 and a period of performance through September 5, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999, to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and federal healthcare providers nationwide.

Generated 12/4/24, 9:02 AM